US equities
|
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Decoy Therapeutics Inc. - Common Stock
(NQ:
DCOY
)
1.520
-0.090 (-5.59%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Decoy Therapeutics Inc. - Common Stock
Unusual volume stocks in Wednesday's session
↗
September 23, 2026
Via
Chartmill
Wednesday's session: top gainers and losers
↗
September 23, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
September 23, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
↗
June 30, 2026
Via
Chartmill
Tuesday's pre-market session: top gainers and losers
↗
June 30, 2026
Via
Chartmill
Wondering what's happening in today's after-hours session?
↗
June 29, 2026
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 29, 2026
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million. Decoy Therapeutics (NASDAQ:DCOY)...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 29, 2026
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million. Decoy Therapeutics...
Via
Benzinga